- Home
- DNLI vs ESE Comparison
DNLI vs ESE Comparison
Compare DNLI & ESE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- ESE
- Stock Information
- Founded
- DNLI 2013
- ESE 1990
- Country
- DNLI United States
- ESE United States
- Employees
- DNLI N/A
- ESE N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- ESE Telecommunications Equipment
- Sector
- DNLI Health Care
- ESE Telecommunications
- Exchange
- DNLI Nasdaq
- ESE Nasdaq
- Market Cap
- DNLI 3.1B
- ESE 3.4B
- IPO Year
- DNLI 2017
- ESE N/A
- Fundamental
- Price
- DNLI $20.73
- ESE $162.12
- Analyst Decision
- DNLI Strong Buy
- ESE Strong Buy
- Analyst Count
- DNLI 13
- ESE 2
- Target Price
- DNLI $37.91
- ESE $147.50
- AVG Volume (30 Days)
- DNLI 814.8K
- ESE 125.6K
- Earning Date
- DNLI 03-04-2025
- ESE 02-06-2025
- Dividend Yield
- DNLI N/A
- ESE 0.19%
- EPS Growth
- DNLI N/A
- ESE 18.29
- EPS
- DNLI N/A
- ESE 4.26
- Revenue
- DNLI N/A
- ESE $1,055,471,000.00
- Revenue This Year
- DNLI N/A
- ESE $14.05
- Revenue Next Year
- DNLI $289.18
- ESE $11.19
- P/E Ratio
- DNLI N/A
- ESE $40.07
- Revenue Growth
- DNLI 204.74
- ESE 8.94
- 52 Week Low
- DNLI $14.56
- ESE $97.11
- 52 Week High
- DNLI $33.33
- ESE $171.28
- Technical
- Relative Strength Index (RSI)
- DNLI 42.56
- ESE 65.15
- Support Level
- DNLI $21.33
- ESE $160.23
- Resistance Level
- DNLI $22.81
- ESE $167.61
- Average True Range (ATR)
- DNLI 1.27
- ESE 6.00
- MACD
- DNLI -0.10
- ESE 1.88
- Stochastic Oscillator
- DNLI 15.83
- ESE 79.56
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG) and RF Shielding and Test (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure and contain magnetic, electromagnetic and acoustic energy.